Kumkumadi Taila Netra Abhyanga and Kumkumadi Bidalak with Ashwagandha Tablet in the treatment and improvement of periocular Dark circle

Evaluation of comparative efficacy of Kumkumadi Taila Netra Abhyanga versus Kumkumadi Bidalak with Ashwagandha Tablet orally in both groups for management of Stress Induced Periocular Hyperpigmentation - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/07/090285

Enrollment

Registered

2025-07-07

Start date

Unknown

Completion date

Unknown

Last updated

2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L814- Other melanin hyperpigmentation

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Age 18 to 45 Individuals with stress Induced periocular hyperpigmentation No prior treatment of periocular hyperpigmentation within 3 months Visible periocular hyperpigmentation Willing to participate and follow full study protocol with written consent Participants with PSS score 14 to 40

Exclusion criteria

Exclusion criteria: Systemic condition such as thyroid diabetes that could interfere with periocular hyperpigmentation. Anemia genetic predisposition allergic dermatitis drug induced Participants with PSS score 0 to 13 Pregnant and breastfeeding women Active eye infection and dermatitis Allergy to any ingredient in the study treatment

Design outcomes

Primary

Measure	Time frame
Improvement in photonumeric scale Improvement in PSS scaleTimepoint: 6 weeks	—

Secondary

Measure	Time frame
Improvement in Visual acuity Improvement in Ocular surface disease index Improvement in schirmer test Tear film break up time improvementTimepoint: 6 weeks	—

Countries

India

Contacts

Public ContactDr Roshna Rathi

Mahatma Gandhi Ayurved College Hospital and Research Centre Salod Wardha

roshana.bhutada@dmiher.edu.in8766866422

Outcome results